Consolidated Balance Sheets - USD ($) $ in Millions		Dec. 31, 2015	Dec. 31, 2014
Current Assets
Cash and cash equivalents (variable interest entities restricted - 2015: $158; 2014: $190)		$ 8,577	$ 5,654
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2015: $94; 2014: $110)		4,078	4,685
Other		3,768	4,687
Inventories		6,871	8,101
Deferred income tax assets - current		827	812
Other current assets		354	316
Total current assets		24,475	24,255
Investments
Investment in nonconsolidated affiliates		3,958	4,201
Other investments (investments carried at fair value - 2015: $1,866; 2014: $2,009)		2,923	2,439
Noncurrent receivables		765	620
Total investments		7,646	7,260
Property
Property		50,802	55,230
Less accumulated depreciation		32,948	37,179
Net property (variable interest entities restricted - 2015: $1,717; 2014: $2,726)		17,854	18,051
Other Assets
Goodwill		12,154	12,632
Other intangible assets (net of accumulated amortization - 2015: $3,770; 2014: $3,737)		3,617	3,768
Deferred income tax assets - noncurrent		1,694	2,135
Asbestos-related insurance receivables - noncurrent		51	62
Deferred charges and other assets		535	524
Total other assets		18,051	19,121
Total Assets	[1]	68,026	68,687
Current Liabilities
Notes payable		454	551
Long-term debt due within one year	[2],[3]	541	382
Accounts payable:
Trade		3,577	4,481
Other		2,287	2,299
Income taxes payable		452	361
Deferred income tax liabilities - current		100	105
Dividends payable		592	563
Accrued and other current liabilities		3,212	2,839
Total current liabilities		11,215	11,581
Long-Term Debt (variable interest entities nonrecourse - 2015: $487; 2014: $1,216)	[2]	16,215	18,741
Other Noncurrent Liabilities
Deferred income tax liabilities - noncurrent		575	622
Pension and other postretirement benefits - noncurrent		9,119	10,459
Asbestos-related liabilities - noncurrent		387	438
Other noncurrent obligations		4,332	3,290
Total other noncurrent liabilities		14,413	14,809
Redeemable Noncontrolling Interest		0	202
Stockholders' Equity
Preferred stock, series A ($1.00 par, $1,000 liquidation preference, 4,000,000 shares)		4,000	4,000
Common stock (authorized 1,500,000,000 shares of $2.50 par value each; issued 2015: 1,242,794,836 shares; 2014: 1,242,763,276 shares)		3,107	3,107
Additional paid-in capital		4,936	4,846
Retained earnings		28,425	23,045
Accumulated other comprehensive loss		(8,667)	(8,017)
Unearned ESOP shares		(272)	(325)
Treasury stock at cost (2015: 125,853,161 shares; 2014: 85,168,571 shares)		(6,155)	(4,233)
The Dow Chemical Company's stockholders' equity		25,374	22,423
Non-redeemable noncontrolling interests		809	931
Total equity		26,183	23,354
Total Liabilities and Equity		$ 68,026	$ 68,687

[1] Presented in accordance with newly implemented ASU 2015-03.

[2] Presented in accordance with newly implemented ASU 2015-03. See Note 2 for further information.

[3] Presented net of current portion of unamortized debt issuance costs of $9 million at December 31, 2015 and$12 million at December 31, 2014.